ZEO ScientifiX and Exotropin Join Forces to Launch a Solution to Address the Growing Unmet Need for Hair Loss
ZEO ScientifiX (OTCQB:ZEOX) has partnered with affiliate Exotropin to launch ZEO HAIR GROW™, a hair growth solution targeting the 66 million Americans affected by hair loss. The system combines extracellular vesicles from amniotic fluid, adipose stromal cells, and aloe vera plant to optimize scalp health. The product consists of three components: ZEO GROW X™ and ZEO GROW BOOST™ for in-office use, and EXO FOLLICLE FUEL™ for at-home application. The solution will be introduced at the Medical Aesthetics Professionals meeting in Scottsdale, Arizona, November 14-16, 2024.
ZEO ScientifiX (OTCQB:ZEOX) ha stretto una partnership con l'affiliata Exotropin per lanciare ZEO HAIR GROW™, una soluzione per la crescita dei capelli destinata ai 66 milioni di americani colpiti dalla perdita di capelli. Il sistema combina vescicole extracellulari dal liquido amniotico, cellule stromali adipose e pianta di aloe vera per ottimizzare la salute del cuoio capelluto. Il prodotto è composto da tre componenti: ZEO GROW X™ e ZEO GROW BOOST™ per uso in ufficio, e EXO FOLLICLE FUEL™ per l'applicazione a casa. La soluzione sarà presentata al meeting dei Professionisti in Estetica Medica a Scottsdale, Arizona, dal 14 al 16 novembre 2024.
ZEO ScientifiX (OTCQB:ZEOX) se ha asociado con la afiliada Exotropin para lanzar ZEO HAIR GROW™, una solución para el crecimiento del cabello dirigida a los 66 millones de estadounidenses afectados por la pérdida de cabello. El sistema combina vesículas extracelulares del líquido amniótico, células estromales adiposas y la planta de aloe vera para optimizar la salud del cuero cabelludo. El producto consta de tres componentes: ZEO GROW X™ y ZEO GROW BOOST™ para uso en consultorios, y EXO FOLLICLE FUEL™ para aplicación en casa. La solución se presentará en la reunión de Profesionales en Estética Médica en Scottsdale, Arizona, del 14 al 16 de noviembre de 2024.
ZEO ScientifiX (OTCQB:ZEOX)는 제휴사 Exotropin과 협력하여 ZEO HAIR GROW™를 출시했습니다. 이 솔루션은 탈모에 영향을 받는 6,600만 미국인을 목표로 하고 있습니다. 이 시스템은 양수에서 추출한 세포외 소포, 지방 기질 세포 및 알로에 베라 식물을 결합하여 두피 건강을 최적화합니다. 이 제품은 세 가지 구성요소로 이루어져 있습니다: ZEO GROW X™와 ZEO GROW BOOST™는 병원에서 사용하고, EXO FOLLICLE FUEL™은 가정에서 사용할 수 있습니다. 이 솔루션은 2024년 11월 14일부터 16일까지 애리조나주의 스코츠데일에서 열리는 의료 미용 전문가 회의에서 소개됩니다.
ZEO ScientifiX (OTCQB:ZEOX) a établi un partenariat avec la société affiliée Exotropin pour lancer ZEO HAIR GROW™, une solution de croissance capillaire visant les 66 millions d'Américains affectés par la perte de cheveux. Le système combine des vésicules extracellulaires provenant du liquide amniotique, des cellules stromales adipeuses et la plante d'aloe vera pour optimiser la santé du cuir chevelu. Le produit se compose de trois éléments : ZEO GROW X™ et ZEO GROW BOOST™ pour une utilisation en cabinet, et EXO FOLLICLE FUEL™ pour une application à domicile. La solution sera introduite lors de la réunion des Professionnels de l'Esthétique Médicale à Scottsdale, en Arizona, du 14 au 16 novembre 2024.
ZEO ScientifiX (OTCQB:ZEOX) hat eine Partnerschaft mit der Schwesterfirma Exotropin geschlossen, um ZEO HAIR GROW™ zu lancieren, eine Haarausfall-Lösung, die sich an die 66 Millionen Amerikaner richtet, die von Haarausfall betroffen sind. Das System kombiniert extrazelluläre Vesikel aus Fruchtwasser, adipoze Stromazellen und die Aloe-Vera-Pflanze zur Optimierung der Gesundheit der Kopfhaut. Das Produkt besteht aus drei Komponenten: ZEO GROW X™ und ZEO GROW BOOST™ für die Anwendung in der Praxis, sowie EXO FOLLICLE FUEL™ für die Anwendung zu Hause. Die Lösung wird auf dem Treffen der Fachleute für medizinische Ästhetik in Scottsdale, Arizona, vom 14. bis 16. November 2024 vorgestellt.
- Addresses large market opportunity of 66 million Americans affected by hair loss
- Partnership leverages complementary expertise in clinical and consumer products
- Multi-component product system combines in-office and at-home treatments
- Product efficacy data and clinical results not provided
- Market entry timeline and revenue projections not disclosed
- Competitive positioning against existing hair loss treatments not addressed
FORT LAUDERDALE, FL / ACCESSWIRE / November 13, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced it has partnered with its affiliate Exotropin, LLC, a privately-held company that produces cosmetics, nutraceuticals, and other consumer products to design and deliver a hair growth solution for people who have considered hair transplant surgery. The companies will introduce their first planned collaborative product, ZEO HAIR GROW™ Powered By Exotropin™, at the Medical Aesthetics Professionals (MAP) meeting being held in Scottsdale, Arizona, from November 14 - 16, 2024.
"Hair loss is becoming more prevalent for both women as well as men. According to the 2020 Practice Census published by the International Society of Hair Restoration Surgery, it is estimated that 35 million men and 31 million women in the United States are affected," said Robin Smith, MD, MBA, co-founder of Exotropin. "Because there are many causes of hair loss, including stress, one's microbiome, hormones, pathogens, inflammations, temperature, genetic predisposition, the environment, and even hairstyles, it is critical to approach hair loss from multiple angles and help optimize the scalp with a nutrient-rich environment to support healthy hair growth."
Dr. Smith explains that ZEO HAIR GROW™ powered by Exotropin™ is a formulated hair system designed for physicians by physicians and scientists that combines the synergistic and complementary power of extracellular vesicles derived from amniotic fluid, adipose stromal cells, and the aloe vera plant to optimize the health of the scalp and encourage a thicker, fuller head of hair.
Essential to the success of the ZEO HAIR GROW™ powered by the Exotropin™ system is the science of extracellular vesicles (EVs) and additional clinically proven ingredients that carry benefits to address the entire hair growth cycle and support skin and hair health. According to Dr. Smith, hair loss is multifactorial, and a true solution to address hair loss must be as well. What is necessary or essential at each phase of the hair growth cycle is not the same, and a comprehensive solution must address the scalp, hair follicles, hair density, thickness, and texture in order to improve the condition and appearance of hair.
The multipart system includes two in-office components consisting of ZEO GROW X™ and ZEO GROW BOOST™, and EXO FOLLICLE FUEL™, which patients use at home twice a day to fortify and maintain both the scalp and hair.
Attendees of the MAP Meeting can learn more about ZEO HAIR GROW™ powered by the Exotropin™ by visiting ZEO in the exhibition area of the conference at Booth 609.
In addition, Dr. Smith will present to the medical aesthetic professionals in attendance, detailing the product's science, development, and application.
For more information about ZEO HAIR GROW™ Powered By Exotropin™, or to schedule an interview with Dr. Smith and the ZEO team in attendance at the MAP Meeting, please contact Meieli Sawyer at msawyer@weinbachgroup.com or 305-668-0070.
About ZEO ScientifiX, Inc.
ZEO ScientifiX, Inc. (OTCQB:ZEOX) is a clinical-stage biopharmaceutical company located at Nova Southeastern University's Collaborative Center for Research. ZEO primarily focuses on the development and research of innovative biological therapeutics for the treatment of chronic diseases and the medical aesthetic market. The Company's proprietary products are derived from allogenic and autologous sources and are manufactured in an FDA-registered, cGMP-compliant laboratory. To learn more, please visit https://zeoscientifix.com/.
About Exotropin, LLC
Exotropin is a U.S. based developer of advanced cosmeceuticals and other physician recommended products using the company's patented eXo3 and aloe3 exosome technology. Exotropin serves the global consumer and medical aesthetic market with scientifically innovative, and result-driven restorative skincare and haircare products. Our mission is to inspire customers to live a more vibrant, healthy life by providing products and services that revive, restore, and renew in all facets of skin and hair needs.
Forward-Looking Statements
Certain statements contained in this press release should be considered forward-looking statements within the meaning of the Securities Act of 1933, as amended (the "Securities Act"), the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by the use of forward-looking terminology such as "will," "believes," "expects," "potential," or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. No assurances can be given that the Company will be successful in its research initiatives. In addition, no assurances can be given that our research initiatives will increase the price of our common stock to a level that is attractive to brokerage houses and institutional investors. We remind you that actual results could vary dramatically as a result of known and unknown risks and uncertainties, including but not limited to: potential issues related to our financial condition, competition, the ability to retain key personnel, product safety, efficacy and acceptance, the commercial success of any new products or technologies, success of clinical programs, ability to retain key customers, our inability to expand sales and distribution channels, legislation or regulations affecting our operations, including product pricing, reimbursement or access, the ability to protect our patents and other intellectual property both domestically and internationally, and other known and unknown risks and uncertainties, including the risk factors discussed in the Company's periodic reports that are filed with the SEC and available on the SEC's website (http://www.sec.gov). You are cautioned not to place undue reliance on these forward-looking statements. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Specific information included in this press release may change over time and may or may not be accurate after the date of the release. ZEO has no intention and specifically disclaims any duty to update the information in this press release.
###
Contact Information
Meieli Sawyer
Director of Communications
msawyer@weinbachgroup.com
305-668-0070
SOURCE: ZEO ScientifiX, Inc.
View the original press release on accesswire.com
FAQ
What is ZEO ScientifiX's (ZEOX) new hair loss treatment product called?
How many Americans are affected by hair loss according to ZEO ScientifiX (ZEOX)?
What technology does ZEO ScientifiX (ZEOX) use in their new hair growth system?
When will ZEO ScientifiX (ZEOX) introduce their new hair growth product?
